Navigation Links
ERT Reports First Quarter 2011 Operating Results
Date:5/2/2011

P gross margin

$
,758

$
9,708

$
8,420Amortization of acquired intangibles and other assets

-

2,288

1,878Non-GAAP gross margin

$
,758

$
21,996

$
20,298Non-GAAP gross margin percentage

53.8%

49.0%

48.7%Non-GAAP gross margin percentage is calculated by dividing non-GAAP gross margin by net revenuesReconciliation of GAAP to Non-GAAPoperating income:GAAP operating income

$
2,747

$
5,230

$
5,354Amortization of acquired intangibles and other assets

-

2,288

1,878Acquisition and integration related costs

741

800

-Non-GAAP operating income

$
3,488

$
8,318

$
7,232Non-GAAP operating income margin percentage

16.0%

18.5%

17.3%Non-GAAP operating income margin percentage is calculated by dividing non-GAAP operating income by net revenuesReconciliation of GAAP to Non-GAAP net income:GAAP net income

$
,752

$
4,120

$
3,093Amortization of acquired intangibles and other assets

-

2,288

1,878Acquisition and integration related costs

741

800

-Income tax effect due to Non-GAAP reconciling items
and other differences between the GAAP and
Non-GAAP effective tax rate

(284)

(1,123)

(502)Non-GAAP net income

$
2,209

$
,085

$
4,469Reconciliation of GAAP to Non-GAAP diluted net income per share:GAAP diluted net income per share

$
.04

$
.08

$
.06Amortization of acquired intangibles and other assets

-

0.05

0.04Acquisition and integration related costs

0.02

0.01

-Income tax effect due to Non-GAAP reconciling items
and other differences between the GAAP and
Non-GAAP effective tax rate

(0.01)

(0.02)

(0.01)Non-GAAP diluted net income per sh
'/>"/>

SOURCE ERT
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
2. Spherix Reports Second Quarter Earnings
3. Tapestry Reports Second Quarter 2007 Results
4. Callisto Reports on Second-Quarter 2007 Milestones
5. ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc.
6. Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs
7. Paper in International Journal of Oncology Reports Alfacells ONCONASE(R) Suppresses Intracellular Oxidative Stress
8. TAXUS WOMAN Study Reports Positive Clinical Outcomes for the TAXUS(R) Drug-eluting Stent in Women
9. Biopure Reports on Meeting with the FDA
10. Peregrine Reports Data Showing Bavituximabs Potential to Shrink Prostate Tumors
11. NicOx Reports TOPIGEN to Advance TPI-1020 Into Phase 2 for COPD Following Promising Clinical Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2015)... 2, 2015  BC Technical, the nation,s leading ... Eclipse Systems, a Nuclear Imaging service company providing ... of their ongoing vision to provide the best, ... BC Technical continues to expand their reach and ... add valuable resources and knowledge in addition to ...
(Date:3/2/2015)... 2, 2015  DURECT Corporation (Nasdaq: ... and the successful completion of a Phase 1 ... DUR-928.  DUR-928 is an endogenous, small-molecule, new chemical ... metabolic diseases such as nonalcoholic fatty liver disease ... organ injuries such as acute kidney injury (AKI).  ...
(Date:3/2/2015)... GERMANTOWN, Md., March 2, 2015  Intrexon Corporation ... synthetic biology, today announced its fourth quarter and ... Business Highlights and Recent Developments: , Acquired ... a new frontier in cellular therapeutics and other ... molecular engineering of food-grade microbes ( Lactococcus lactis ...
Breaking Medicine Technology:BC Technical Acquires Eclipse Systems 2DURECT Announces Epigenomic Regulator Program including a New NAFLD/NASH and Acute Organ Injury Product Candidate in Development 2DURECT Announces Epigenomic Regulator Program including a New NAFLD/NASH and Acute Organ Injury Product Candidate in Development 3DURECT Announces Epigenomic Regulator Program including a New NAFLD/NASH and Acute Organ Injury Product Candidate in Development 4DURECT Announces Epigenomic Regulator Program including a New NAFLD/NASH and Acute Organ Injury Product Candidate in Development 5Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 2Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 3Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 4Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 5Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 6Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 7Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 8Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 9Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 10Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 11Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 12Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 13Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 14Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 15Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 16Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 17Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 18Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 19Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 20Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 21Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 22Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 23Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results 24
... N.J., April 12, 2011 Novartis Pharmaceuticals Corporation ... Drug Administration (FDA) Oncologic Drugs Advisory Committee (ODAC) ... treatment of patients with advanced neuroendocrine tumors (NET) ... provided after presentation of data from the everolimus ...
... 2011 Havel,s market leading EchoStim® Echogenic Insulated ... to perform Peripheral Nerve Blocks (PNBs) using nerve ...  The new improved needle has more, brighter, easier ... giving even inexperienced practitioners the benefits of using ...
Cached Medicine Technology:Novartis Drug Afinitor® Recommended by FDA Oncology Advisory Committee for Approval to Treat Advanced NET of Pancreatic Origin 2Novartis Drug Afinitor® Recommended by FDA Oncology Advisory Committee for Approval to Treat Advanced NET of Pancreatic Origin 3Novartis Drug Afinitor® Recommended by FDA Oncology Advisory Committee for Approval to Treat Advanced NET of Pancreatic Origin 4Novartis Drug Afinitor® Recommended by FDA Oncology Advisory Committee for Approval to Treat Advanced NET of Pancreatic Origin 5Novartis Drug Afinitor® Recommended by FDA Oncology Advisory Committee for Approval to Treat Advanced NET of Pancreatic Origin 6Novartis Drug Afinitor® Recommended by FDA Oncology Advisory Committee for Approval to Treat Advanced NET of Pancreatic Origin 7Novartis Drug Afinitor® Recommended by FDA Oncology Advisory Committee for Approval to Treat Advanced NET of Pancreatic Origin 8Novartis Drug Afinitor® Recommended by FDA Oncology Advisory Committee for Approval to Treat Advanced NET of Pancreatic Origin 9Novartis Drug Afinitor® Recommended by FDA Oncology Advisory Committee for Approval to Treat Advanced NET of Pancreatic Origin 10
(Date:3/2/2015)... Birmingham, Alabama (PRWEB) March 02, 2015 ... Alabama - In conjunction with Women in Construction Week ... in Construction, or NAWIC) and National Women’s History Month, ... and commitment positively affect the company and the construction ... the management team, to the dozens of roles in ...
(Date:3/2/2015)... March 02, 2015 New York ... Unplugged™—will be delivering a plenary address entitled Finding ... the Art of Healing and Recovery at this ... Behavioral Healthcare Executive Summit (BHES).     , With more ... songs have been recorded by some of the ...
(Date:3/2/2015)... March 02, 2015 Representatives with ... has officially launched a multivitamin supplement that’s specifically ... product development for BNatrl, said the multivitamin, which ... Olympic and other world-class athletes. , "Being an ... this pure whole food multivitamin to improve my ...
(Date:3/2/2015)... March 02, 2015 LegitScript, ... healthcare certification programs, including those for Internet ... supplement safety and classification, has launched a ... eyeglasses. The new program, called iCareRx ... transparency regarding the identity of the owner/operator ...
(Date:3/2/2015)... 2015 Four Seasons Resort Maui at Wailea, ... anniversary this year, having officially opened its doors on March ... is honoring over 70 employees who started on Day 1 ... the approximately 400 original employees. The celebration will be ... , This Four Seasons flagship resort, the first ...
Breaking Medicine News(10 mins):Health News:Robins & Morton Recognizes Women In Construction 2Health News:Richie Supa Announced as a Plenary Speaker at NCAD 2015 2Health News:Bnatrl Launches Multivitamin Supplement for Runners 2Health News:LegitScript Launches Certification Program for Internet Eyeglass Sellers 2Health News:Celebrating Four Seasons Resort Maui’s 25th Anniversary 2
... shot, if you can find one , , BALTIMORE, June ... in late February, the Centers for Disease Control (CDC) says there ... this time of year. According to health officials, it is not ... , , Those who are in higher risk groups should ...
... ... proportions in the United States, Snoring Isn,t Sexy, LLC announces an initiative to have all ... ... obstructive sleep apnea is reaching almost epidemic proportions in the United States, Snoring Isn,t Sexy, ...
... ... MaddoxOncology.com is making it easier for cancer patients to find products to relieve the side-effects ... care, skin care, and anti-nausea products--all in one place. , ... Holly Springs, NC (PRWEB) June 2, 2009 -- Dealing with ...
... ... Journal of Naturopathic Medicine, a first of its kind, peer-reviewed journal that serves as a ... . , ... June 2, 2009 -- Practitioners of natural medicine attained a new voice June ...
... June 2 The University HealthSystem Consortium (UHC) today ... been added to Spend LINK (TM), UHC,s proprietary supply ... (AMCs) optimize their pricing and achieve maximum savings. ... a hospital,s expenditure, making it the second largest expense ...
... June 1 Neurosurgeons, brain tumor researchers and other professionals ... will present a one-day conference, "Outsmarting Brain Tumors," ... The free conference is designed for brain tumor patients, families ... Harvey Morse Auditorium, 8700 Beverly Blvd., Los Angeles, CA 90048. ...
Cached Medicine News:Health News:Seasonal Flu Lingers 2Health News:Founder of Snoring Isn't Sexy, LLC Urges All Dentists to Screen Their Patients for Snoring and Obstructive Sleep Apnea 2Health News:Mother and Son Provide Products to Ease Side-Effects of Cancer Treatments 2Health News:Mother and Son Provide Products to Ease Side-Effects of Cancer Treatments 3Health News:New Journal of Natural Medicine Launched This June, Promotes Natural Therapy 2Health News:University HealthSystem Consortium Adds Price Competitive Index to Its Spend Analytics Tool 2Health News:'Outsmarting Brain Tumors': Cedars-Sinai Researchers, Neurosurgeons and Other Experts Present Free Conference for Adult Brain Tumor Patients and Caregivers 2
Antigenic Free Protein S, ELISA Method...
... Clotting Assay for ... the Functional Protein S ... of Factor Va Inhibition ... Human Plasma, free of ...
Colorimetric Assay of Protein C Activity by STA© Analyzers. Highly purified extract of Agkistrodon c. contortrix venom for specific activation of protein C, with an activator selected specially ...
Colorimetric Assay of Antithrombin III Activity by STA© Analyzers. Bovine thrombin ~12NIH units/mL, freeze-dried....
Medicine Products: